Tag: Drug candidates

Browse exclusive Tags!

RAPT Therapeutics Reports Q3 Financial Results and Promising Progress in Clinical Trials

RAPT Therapeutics reports Q3 2023 financial results and positive progress in clinical trials. Discover their promising immunology-based therapies. Read now!

German company Dynamic42 secures Series A funding to expand globally with their organ-on-chip technology.

Dynamic42 secures mid-seven-figure financing to expand globally and enter the US pharmaceutical market. Their organ-on-chip tech provides better alternatives for drug testing, reducing animal testing and increasing drug safety.

Popular

German company Dynamic42 secures Series A funding to expand globally with their organ-on-chip technology.

Dynamic42 secures mid-seven-figure financing to expand globally and enter the US pharmaceutical market. Their organ-on-chip tech provides better alternatives for drug testing, reducing animal testing and increasing drug safety.

Subscribe

spot_imgspot_img